Results 141 to 150 of about 3,822 (260)

Prediction model of platelet transfusion refractoriness in patients with hematological disorders

Zhongguo shuxue zazhi
Objective To explore the risk factors for platelet transfusion refractoriness(PTR)in patients with hematological disorders, construct a prediction model and validate the model efficacy.
Shuhan YUE, Xiulan HUANG, Yan ZENG, Qiao LEI, Mengzhen HE, Liqi LU, Shisong YOU, Jingwei ZHANG   +7 more
doaj   +1 more source

HLA‐matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening [PDF]

, 2019
Aukje L. Kreuger, Anja BU Mäkelburg, Judith A.E. Somers, Bert Tomson, Leo M.G. van de Watering, Johanna G. van der Bom, Marian G.J. van Kraaij, Claudia M Weller   +7 more
openalex   +1 more source

Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions

The Turkish Journal of Pediatrics, 2003
Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte ...
Omer Devecioğlu, Ayşegül Unüvar, Sema Anak, Ilmay Bilge, Haluk Ander, Orhan Ziylan   +5 more
doaj  

Immunological platelet transfusion refractoriness: current insights from mechanisms to therapeutics

Platelets
Although there have been tremendous improvements in the production and storage of platelets, platelet transfusion refractoriness (PTR) remains a serious clinical issue that may lead to various severe adverse events.
Xiaoyu Chen, Yuhong Zhao, Yan Lv, Jue Xie   +3 more
doaj   +1 more source

Anti‐HLA alloantibodies in surgical patients refractory to platelet transfusion [PDF]

, 2014
J Peña, Susan L. Saidman, Timothy C. Girouard, Erin Meister, Sunny Dzik, Robert S. Makar   +5 more
openalex   +1 more source

Use of Human Leukocyte Antigen (HLA)–Incompatible Platelet Units in HLA Platelet-Refractory Patients With Limited Number of or Low-Level HLA Donor-Specific Antibodies Results in Permissive Transfusions [PDF]

, 2022
Jensyn Cone Sullivan, Jeremy Ryan Peña
openalex   +1 more source

Occurence and dynamics of HLA and HPA antibodies in the setting of matched related HSCT [PDF]

, 2018
Bräutigam, Michelle, Buser, Andreas, Drexler, Beatrice, Halter, Jörg, Heim, Dominik, Holbro, Andreas, Infanti, Laura, Passweg, Jakob R, Plattner, Alexandra, Volken, Thomas   +9 more
core   +1 more source

Anti-HPA-5a antibody as a possible cause of platelet transfusion refractoriness in a patient with acute myelogenous leukemia.

, 1999
Etsuko Lee, Kimiyo Shinohara, Hirofumi Watanabe, Masao Hirose, Ken-ichi Kitazoe, Miyoko Fukui, Youichi Katsuura, Atsuko Taniue, Nobuo Nagao, Yasuhiro Kuroda   +9 more
openalex   +2 more sources

Can we “terminate” alloimmune platelet transfusion refractoriness? [PDF]

Transfusion, 2016
Ralph R, Vassallo, Philip J, Norris
openaire   +2 more sources

Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit [PDF]

, 2015

core   +1 more source